The study showed that using the drug dicyclomine ... drugs like docetaxel are among very few options available to patients with castration-resistant prostate cancer, a lethal form of the disease ...

Docetaxel had previously been shown to be more effective than doxorubicin for treating patients with advanced breast cancer. Therefore, researchers wanted to test the drug in patients receiving ...

drug-resistant prostate cancer." More information: Maximilian P. Brandt et al, Inhibition of the Sterol Regulatory Element Binding Protein SREBF-1 Overcomes Docetaxel Resistance in Advanced ...

SAN DIEGO — The novel antibody-drug conjugate tusamitamab ravtansine (tusa rav, Sanofi) did not demonstrate greater efficacy than docetaxel in treating advanced nonsquamous non–small cell lung ...

The approval was based on data from the phase 3 ARASENS trial. The Food and Drug Administration (FDA) has approved Nubeqa ® (darolutamide), an androgen receptor inhibitor, in combination with ...

Docetaxel (Sanofi-Aventis) is an anti-neoplastic drug that belongs to a class of drugs known as taxanes. It works by disrupting the microtubular network that is essential for mitotic and interphase ...